Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Gland Pharma Ltd. ( (IN:GLAND) ).
Gland Pharma Limited has announced a significant change in its leadership structure. Effective January 16, 2025, Mr. Shyamakant Giri will take over as the Chief Executive Officer. Mr. Srinivas Sadu will continue his role as Executive Chairman, supporting the company’s future growth plans. This leadership transition indicates a strategic move to bolster Gland Pharma’s operations and growth trajectory, potentially impacting its market positioning positively.
More about Gland Pharma Ltd.
YTD Price Performance: -7.85%
Average Trading Volume: 12,481
Current Market Cap: 274.8B INR
For a thorough assessment of GLAND stock, go to TipRanks’ Stock Analysis page.